OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin

HTML

Year: 2001
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2001.19.12.3130
Authors: Ronald A. Peck, Jan Hewett, Matthew W. Harding, Yow-Ming Wang, Pravin R. Chaturvedi, Anish Bhatnagar, Harvey Ziessman, Frank Atkins, Michael J. Hawkins
Institution: Georgetown University
Language: English

Topic: Drug Transport and Resistance Mechanisms
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: P-glycoprotein inhibitors, multidrug resistance reversal, doxorubicin, pharmacokinetics, safety and tolerability, 99mTc-sestamibi, hepatic uptake, refractory solid tumors, drug resistance, central nervous system toxicity, febrile neutropenia, combination chemotherapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2259308424
FWCI: 5.629
Cites: 58
Cited by: 111
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security